| Literature DB >> 23865624 |
Kathrin Rauh, Elisabeth Gabriel, Eva Kerschbaum, Tibor Schuster, Ruediger von Kries, Ulrike Amann-Gassner, Hans Hauner.
Abstract
BACKGROUND: Excessive gestational weight gain (GWG) is associated with short- and long-term health problems among mothers and their offspring. There is a strong need for effective intervention strategies targeting excessive GWG to prevent adverse outcomes.Entities:
Mesh:
Year: 2013 PMID: 23865624 PMCID: PMC3718707 DOI: 10.1186/1471-2393-13-151
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Figure 1Flow diagram of the FeLIPO trial.
Baseline characteristics of the study population
| 30.8 ± 4.9 | 32.2 ± 4.4 | ||
| 168 ± 6 | 169 ± 6 | 0.202 | |
| 63.0 (57.8 - 76.0) | 62.0 (56.0 - 69.0) | ||
| 22.8 (20.6 - 26.6) | 21.7 (19.9 - 23.7) | ||
| 64.9 (59.4 - 78.1) | 63.7 (58.0 - 70.8) | ||
| 23.3 (21.2 - 26.8) | 22.2 (20.7 - 24.3) | ||
| 7 (6 - 8) | 9 (8 - 11) | ||
| | | | |
| | 57 (68.7) | 140 (83.8) | |
| | 15 (18.1) | 20 (12.0) | |
| | 11 (13.3) | 7 (4.2) | |
| | | | |
| | 53 (63.9) | 110 (65.9) | 0.385 |
| | 23 (27.7) | 50 (29.9) | |
| | 7 (8.4) | 7 (4.2) | |
| | | | |
| | 68 (81.9) | 140 (83.8) | 0.704 |
| | 15 (18.1) | 27 (16.2) | |
| | | | |
| | 48 (57.8) | 96 (57.5) | 0.958 |
| | 35 (42.2) | 71 (42.5) | |
| | | | |
| | 7 (8.4) | 8 (4.8) | 0.101 |
| | 24 (28.9) | 30 (18.0) | |
| | 15 (18.1) | 32 (19.2) | |
| | 37 (44.6) | 97 (58.1) | |
| | | | |
| | 52 (62.7) | 103 (61.7) | 0.502 |
| | 17 (20.5) | 43 (25.7) | |
| | 14 (16.9) | 21 (12.6) | |
| | | | |
| | 77 (92.8) | 157 (94.0) | 0.706 |
| | 6 (7.2) | 10 (6.0) |
Data are given as mean ± standard deviation, median (interquartile range) or number (%).
BMI = Body mass index.
a) Mann–Whitney U test for metrical, χ2 test for categorical variables.
b) Self-reported c) Measured weight at the first antenatal visit.
d) Control n = 82; Intervention n = 163.
Gestational weight gain and postpartum weight retention in the control versus the intervention group
| n = 74 | n = 152 | | | | | |
| 15.6 ± 5.8 | 14.1 ± 4.1 | −1.4 (−2.7 to −0.1) | −1.7 (−3.0 to −0.3) | |||
| 44 (59.5) | 58 (38.2) | 0.4 (0.2 to 0.7) | 0.5 (0.3 to 0.9) | |||
| 14 (18.9) | 32 (21.1) | 1.1 (0.6 to 2.3) | 0.709 | 1.0 (0.5 to 2.1) | 0.973 | |
| n = 72 | n = 152 | | | | | |
| 123 (119–129) | 123 (121–128) | | | | | |
| 3.3 ± 5.1 | 2.1 ± 4.3 | −1.1 (−2.4 to 0.2) | 0.090 | −1.4 (−2.7 to −0.2) | 0.070 | |
| 22 (30.6) | 26 (17.1) | 0.5 (0.2 to 0.9) | 0.5 (0.2 to 0.9) |
GWG = Gestational weight gain, IOM = Institute of Medicine, pp = postpartum.
Data are given as means ± SD, median (interquartile range) or number (%).
Effect sizes from regression models: Continuous variables as estimated marginal mean difference (95% CIs) and categorized variables as odds ratios (95% CIs).
a) Unadjusted analysis.
b) Linear or generalized linear mixed model adjusted for cluster (random factor), age and prepregnancy BMI (in analysis of total weight gain and weight retention) / prepregnancy BMI category (in analysis of excessive/inadequate GWG).
Pregnancy and birth related outcomes in the control versus the intervention group
| 3,414 ± 445 | 3,406 ± 402 | −8 (−122 to 106) | 0.890 | 29 (−85 to 143) | 0.637 | |
| 51.7 ± 2.4 | 51.4 ± 2.4 | −0.3 (−0.1 to 0.3) | 0.351 | −0.2 (−1.1 to 0.8) | 0.728 | |
| 9 (12.2) | 8 (5.4) | 0.4 (0.2 to 1.1) | 0.084 | 0.5 (0.2 to 1.4) | 0.183 | |
| | | | | | | |
| | 35 (44.3) | 91 (58.3) | ref. | | ref. | |
| | 33 (41.8) | 47 (30.1) | 0.6 (0.3 to 1.1) | 0.076 | 0.6 (0.4 to 1.2) | 0.145 |
| | 11 (13.9) | 18 (11.5) | 0.8 (0.4 to 1.8) | 0.600 | 0.8 (0.3 to 2.1) | 0.666 |
| 29 (36.7) | 40 (25.6) | 0.6 (0.3 to 1.1) | 0.080 | 0.6 (0.3 to 1.3) | 0.191 | |
| 5 (6.3) | 4 (2.6) | 0.4 (0.1 to 1.5) | 0.169 | 0.3 (0.1 to 1.2) | 0.088 | |
| | | | | | | |
| | 37 (46.8) | 72 (46.2) | ref. | | ref. | |
| | 42 (53.2) | 84 (53.8) | 1.0 (0.6 to 1.8) | 0.921 | 1.1 (0.6 to 1.8) | 0.865 |
| 7 (8.9) | 10 (6.4) | 0.7 (0.3 to 1.9) | 0.495 | 0.8 (0.3 to 2.3) | 0.702 | |
| 3 (3.8) | 6 (3.8) | 1.0 (0.2 to 4.2) | 0.985 | 1.0 (0.2 to 4.9) | 0.990 |
GDM = Gestational diabetes mellitus; IGT = Impaired glucose tolerance.
Data are given as means ± SD or number (%).
Effect sizes from regression models: Continuous variables as estimated marginal mean difference (95% CIs) and categorized variables as odds ratios (95% CIs).
a) Unadjusted analysis; b) Linear or generalized linear mixed model adjusted for cluster (random factor), age and prepregnancy BMI.
c) In 221 (Control n = 74, Intervention n = 147) women a standardized 2 h oral glucose tolerance test was performed; GDM or IGT was defined according to the clinical practice guidelines of the German Society of Gynecology and Obstetrics from 2010 [69].
Energy intake and total physical activity in the control versus the intervention group
| | n = 47 | n = 121 | | |
| | | | | |
| | 2,110 ± 409 | 2,195 ± 387 | −115 (−221 to −8) | |
| | | 2,174 ± 331 | | |
| | 2,328 ± 410 | 2,215 ± 347 | | |
| | 0.928 | | | |
| | n = 55 | n = 118 | | |
| | | | | |
| | 3,186 (1,711 - 4,932) | 2,573 (1,605 - 4,488) | 207 (−304 to 717) | 0.425 |
| | 2,826 (1,480 - 5,455) | 2,529 (1,477 - 4,282) | | |
| | 2,232 (1,410 - 3,685) | 1,968 (1,257 - 3,336) | | |
| 0.198 |
Wk = week.
Data are given as means ± SD or median (interquartile range), effect sizes as estimated marginal mean difference and 95% CIs.
a) P values for effect of intervention between groups (repeated-measurements ANOVA adjusted by baseline values).
b) Differences within groups (Friedman or Wilcoxon test).